In conclusion, our data need to be verified in larger SSc cohorts with a longer follow-up evaluating periostin circulating levels and its expression on involved and uninvolved skin samples to identify those patients that are at a higher risk of cutaneous progression. Here, POSTN is linked to systemic sclerosis.